The sweetheart of a strong president

Now, with the emergence of new technologies, such as liquid biopsy and gene sequencing, we have more opportunities to detect tumors at an early stage. These technologies not only promote the development of personalized medicine, but also provide tools for formulating more effective public health strategies. We have reason to believe that there will be more innovative methods in the future to help us defeat cancer at an early stage. Please feel free to discuss below.

The goal of today's meeting is to first determine a research goal. If you think my proposal is not feasible, you can propose alternative plans and discuss them together and vote by raising your hands.

After Su Wan finished speaking, everyone started a heated discussion, focusing on the following aspects.

Technical feasibility: Participants may assess the current technical maturity of combining AI and early tumor diagnosis, including data acquisition, analysis capabilities, and the possibility of integration into clinical workflows.

Market demand analysis: Discussions may involve a demand analysis of existing markets, identifying target audiences (e.g., high-risk populations, screening centers, hospitals, etc.), and considering potential market size and growth potential.

Ethical and Privacy Issues: During the discussion, participants will need to address ethical and privacy issues related to the collection, processing, and protection of patient data.

Regulation and Approvals: The regulatory requirements necessary to develop such a device will be considered, including the process and timeline for obtaining FDA approval, as well as compliance for rollout in different countries and regions.

Funding and Resources: The funding needs of the project will be discussed, including R&D costs, team building, and the search for partners or investors.

Development Plan and Timeline: Participants will develop a detailed development plan and implementation timeline to ensure the project progresses according to phases and set milestones.

Risk Assessment: Team members may discuss potential risks of the project, including technology failure, poor market acceptance, competitor products, and R&D cost overruns.

The meeting was extremely lively, and everyone had in-depth discussions on various topics. At this critical moment, Su Wan did not express her own views, but quietly left the meeting room and wandered alone in the stairwell. Her thoughts had drifted to other problems that needed to be solved urgently.

Mr. Li also came out and saw Su Wan looking absent-minded, so he became concerned.

"Why? You feel stressed."

"No, I am confident. It's just that funding may be a problem. It may be the main reason that hinders the speed of research and development."

"Then according to Mr. Su's considerations..."

"You are the president, why should I consider it?"

"Loans and financing may not be able to completely solve the problem. We still need to think of other channels."

"Let me think about it." She thought of Lan Lan.

Lan Lan has some connections in the investment community and can help the company solve some of its funding gap problems.

But she didn't know that Lan Lan's ability alone was far from enough to solve the problem.

"Don't be too tired, take care of yourself." Mr. Li really cares about her. He knows that she has made sufficient preparations for the tumor product project and has done a lot of homework in private some time ago. The company cannot do without her.

He can't live without her either. Watching her from afar is also a kind of spiritual comfort, isn't it?

"If anything goes wrong with you, I won't be able to explain to General Lin," he joked, "I can't forgive myself either."

"Thank you for your concern, Mr. Li." She smiled faintly, and that smile was filled with a melancholy beauty. This beauty penetrated into Mr. Li's heart. His heart sank, and he felt helpless.

The meeting ended and the results of the discussion were summarized into the following resolutions.

The development of AI-based early tumor diagnostic instruments was identified as a common research goal, and clear milestones and timelines were defined for its success.

Alternatives were listed and discussed, but after a vote, it was agreed to focus on the originally proposed project first.

Roles and responsibilities were assigned, working groups were established, and budgets and progress monitoring methods were determined.

Developed risk management plans and response strategies.

The next course of action was determined, including the start of necessary scientific research experiments, technology development, market research and fund-raising activities.

Such discussions and results will lay a solid foundation for the development of AI-based early tumor diagnosis application instruments and provide clear direction and goals for the entire project.

Lan Lan arrived at the hotel exhausted and saw Mr. Li and Su Wan were already waiting for her.

Su Wan had already explained the fundraising matter to her over the phone. She felt the amount was too large, so she came over in person to find out.

Mr. Li asked the waiter to pour her a glass of water. She took a sip and said, "Mr. Li, Su Wan, you really think too highly of me. I am just a small fry. I am afraid it will be difficult to raise such a huge amount of funds. I can help you think of a solution. I advise you not to have too high expectations."

As they were talking, the food and wine were served.

The three of them talked and chatted.

"Mr. Li, why don't you take out a loan? You can try government subsidies, financing, crowdfunding...all kinds of ways."

“We are, of course, taking it step by step.”

"Su Wan, can President Lin also help?" As soon as the words came out of his mouth, he immediately realized that he had said the wrong thing.

Fortunately, Mr. Li responded with a sentence, which relieved the awkwardness.

"Boss Lin has invested 100 billion in our company. We can't trouble him anymore. His company is not doing well either."

"100 million?"

Lan looked at Su Wan meaningfully.

Lan Lan's face seemed to say: I'm willing to spend 100 billion on you, and yet I still say other people are not good enough. How greedy!

But he said, "Boss Lin is really quick to act! How much money do you want to earn? You're always tossing around. Can't you earn less money and spend more time with your wife and kids?"

"Su Wan hasn't said anything yet, but you're so indignant?"

Mr. Li smiled and glanced at Su Wan.

"She is such a kind person. She would go through fire and water for me."

At this time, Mr. Li's phone rang.

"It's Mr. Lin's call?" He answered, "Hello, Mr. Lin!..."

Lin Zihan said that he saw their company's fundraising announcement and was interested in investing. He wanted to meet with Mr. Li, but he asked him not to tell Su Wan.

Mr. Li nodded repeatedly, put down the phone, said he had something to do, and left first.

"Su Wan, this is your retribution, right? If you hadn't gotten into such a fight with Boss Lin, why would you be so anxious about raising funds?"

"It seems like the person is very willing to do this!" Su Wan glanced at her and said, "We have been together for so many years, I am not uncomfortable!"

"Do you regret it?" Lan Lan asked deliberately.

"Lan, this is a matter of principle, personality, dignity, and freedom. I would rather have no money for research and development than lose these," she said thoughtfully.